ZA973538B - Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression. - Google Patents
Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression.Info
- Publication number
- ZA973538B ZA973538B ZA9703538A ZA973538A ZA973538B ZA 973538 B ZA973538 B ZA 973538B ZA 9703538 A ZA9703538 A ZA 9703538A ZA 973538 A ZA973538 A ZA 973538A ZA 973538 B ZA973538 B ZA 973538B
- Authority
- ZA
- South Africa
- Prior art keywords
- brain
- depression
- treatment
- acid esters
- phosphonic acid
- Prior art date
Links
- 210000004556 brain Anatomy 0.000 title 1
- 150000003008 phosphonic acid esters Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19616471A DE19616471A1 (de) | 1996-04-25 | 1996-04-25 | Phosponsäureester zur Behandlung von Hirnleistungsstörungen und Depressionen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA973538B true ZA973538B (en) | 1997-11-18 |
Family
ID=7792381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9703538A ZA973538B (en) | 1996-04-25 | 1997-04-24 | Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0896540A1 (es) |
| JP (1) | JP2000510455A (es) |
| KR (1) | KR20000010611A (es) |
| AR (1) | AR006870A1 (es) |
| AU (1) | AU2462397A (es) |
| BG (1) | BG102864A (es) |
| BR (1) | BR9709300A (es) |
| CA (1) | CA2252567A1 (es) |
| CZ (1) | CZ343498A3 (es) |
| DE (1) | DE19616471A1 (es) |
| HU (1) | HUP9903366A3 (es) |
| ID (1) | ID16678A (es) |
| IL (1) | IL126698A0 (es) |
| NO (1) | NO984964L (es) |
| PL (1) | PL333464A1 (es) |
| SK (1) | SK146398A3 (es) |
| TR (1) | TR199802137T2 (es) |
| WO (1) | WO1997039756A1 (es) |
| ZA (1) | ZA973538B (es) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1078370B (de) * | 1958-09-16 | 1960-03-24 | Norddeutsche Affinerie | Schaedlingsbekaempfungsmittel |
| US3069312A (en) * | 1960-09-28 | 1962-12-18 | California Research Corp | N-substituted dimethyl 1-carbamoyloxy-2, 2, 2-trichloroethyl phosphonates as insecticidal compositions |
| NL292791A (es) * | 1962-05-16 | 1900-01-01 | ||
| DE1193044B (de) * | 1963-08-05 | 1965-05-20 | Bayer Ag | Verfahren zur Herstellung phosphorylierter Urethane |
| DE2512375A1 (de) * | 1975-03-21 | 1976-09-30 | Bayer Ag | 1-hydroxy-2,2,2-trichloraethan- thionophosphonsaeuredialkylester, verfahren zu ihrer herstellung sowie ihre verwendung als insektizide |
| US4950658A (en) * | 1988-12-06 | 1990-08-21 | Board Of Trustees Of Southern Illinois Univ. | Method of medical treatment of Alzheimer's disease |
-
1996
- 1996-04-25 DE DE19616471A patent/DE19616471A1/de not_active Withdrawn
-
1997
- 1997-04-17 CZ CZ983434A patent/CZ343498A3/cs unknown
- 1997-04-17 HU HU9903366A patent/HUP9903366A3/hu unknown
- 1997-04-17 PL PL97333464A patent/PL333464A1/xx unknown
- 1997-04-17 SK SK1463-98A patent/SK146398A3/sk unknown
- 1997-04-17 JP JP09538197A patent/JP2000510455A/ja active Pending
- 1997-04-17 KR KR1019980708502A patent/KR20000010611A/ko not_active Application Discontinuation
- 1997-04-17 BR BR9709300A patent/BR9709300A/pt not_active Application Discontinuation
- 1997-04-17 TR TR1998/02137T patent/TR199802137T2/xx unknown
- 1997-04-17 WO PCT/US1997/006469 patent/WO1997039756A1/en not_active Application Discontinuation
- 1997-04-17 AU AU24623/97A patent/AU2462397A/en not_active Abandoned
- 1997-04-17 CA CA002252567A patent/CA2252567A1/en not_active Abandoned
- 1997-04-17 IL IL12669897A patent/IL126698A0/xx unknown
- 1997-04-17 EP EP97920431A patent/EP0896540A1/en not_active Withdrawn
- 1997-04-24 ZA ZA9703538A patent/ZA973538B/xx unknown
- 1997-04-24 ID IDP971362A patent/ID16678A/id unknown
- 1997-04-25 AR ARP970101724A patent/AR006870A1/es unknown
-
1998
- 1998-10-22 BG BG102864A patent/BG102864A/xx unknown
- 1998-10-23 NO NO984964A patent/NO984964L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ID16678A (id) | 1997-10-30 |
| SK146398A3 (en) | 1999-06-11 |
| CZ343498A3 (cs) | 1999-02-17 |
| PL333464A1 (en) | 1999-12-20 |
| AR006870A1 (es) | 1999-09-29 |
| BG102864A (en) | 1999-09-30 |
| HUP9903366A3 (en) | 2000-08-28 |
| WO1997039756A1 (en) | 1997-10-30 |
| HUP9903366A2 (en) | 2000-07-28 |
| TR199802137T2 (xx) | 1999-02-22 |
| DE19616471A1 (de) | 1997-10-30 |
| NO984964D0 (no) | 1998-10-23 |
| BR9709300A (pt) | 1999-08-10 |
| EP0896540A1 (en) | 1999-02-17 |
| AU2462397A (en) | 1997-11-12 |
| CA2252567A1 (en) | 1997-10-30 |
| IL126698A0 (en) | 1999-08-17 |
| NO984964L (no) | 1998-12-22 |
| JP2000510455A (ja) | 2000-08-15 |
| KR20000010611A (ko) | 2000-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6396598A (en) | Arylsulphonamides and analogues and their use for the treatment and neurovegetative disorders | |
| IL133800A0 (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders | |
| HUP9800033A3 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| AU5981098A (en) | Therapeutic gestagens for the treatment of premenstrual dysphoric disorder | |
| AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
| PL339425A1 (en) | Treatment of behavioural disorders | |
| EP0647134A4 (en) | METHODS AND COMPOSITIONS USED TO TREAT DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (-). | |
| AU7528001A (en) | The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders | |
| ZA977310B (en) | Transdermal propentofylline compositions for the treatment of Alzheimer's disease. | |
| AU2058697A (en) | Treatment of sleep disorders | |
| IL129144A0 (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases | |
| AU1578295A (en) | Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders | |
| EP1126850A4 (en) | TREATMENT OF CONDITIONS OF THE RETINA | |
| HK1022267A1 (en) | Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis | |
| IL152688A0 (en) | Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system | |
| EP0968716A4 (en) | MEDICINES FOR THE TREATMENT OF EYE CIRCULATORY DISORDERS | |
| IL131347A0 (en) | Treatment of skin disorders | |
| ZA9710141B (en) | Process for the preparation of salts and esters of clauvulanic acid. | |
| ZA973538B (en) | Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression. | |
| AU5446798A (en) | Compositions and methods for the treatment of gastrointestinal disorders | |
| ZA985818B (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders. | |
| AU9162298A (en) | Use of cyclic phosphonic acid esters for the treatment of impaired cerebral function and depression | |
| ZA9610264B (en) | Preparation for use in the treatment of skin disorders. | |
| AU8976598A (en) | Budipine in the treatment of inflammatory disorders of the nervous system | |
| AU4486797A (en) | Compositions and methods useful for the treatment of neurological and mental disorders |